Literature DB >> 3501437

Pancytopenia induced by the interaction between methotrexate and trimethoprim-sulfamethoxazole.

D R Thomas, J S Dover, R D Camp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501437     DOI: 10.1016/s0190-9622(87)80490-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  7 in total

1.  Methotrexate-induced pancytopenia associated with co-prescription of penicillin and trimethoprim.

Authors:  Navtej Sathi; Julie Dawson
Journal:  Clin Rheumatol       Date:  2006-08-29       Impact factor: 2.980

2.  Methotrexate and trimethoprim-sulfamethoxazole: toxicity from this combination continues to occur.

Authors:  Jessica Cudmore; Matthew Seftel; Jeffrey Sisler; Ryan Zarychanski
Journal:  Can Fam Physician       Date:  2014-01       Impact factor: 3.275

Review 3.  Pharmacological therapy for Wegener's granulomatosis.

Authors:  Eric S White; Joseph P Lynch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  Comparative tolerability of systemic treatments for plaque-type psoriasis.

Authors:  Stacy L McClure; Jayme Valentine; Kenneth B Gordon
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 5.  Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.

Authors:  Gil Yosipovitch; Mark B Y Tang
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 6.  The practical use of methotrexate in psoriasis.

Authors:  J P Tung; H I Maibach
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

7.  A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole.

Authors:  Mohsin Hamid; Bilal Lashari; Irfan Ahsan; Ida Micaily; Usman Sarwar; Joseph Crocetti
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.